Mercados españoles abiertos en 6 hrs 28 min

Indaptus Therapeutics, Inc. (INDP)

NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
2,0500+0,0200 (+0,99%)
Al cierre: 04:00PM EDT
2,1200 +0,07 (+3,41%)
Después del cierre: 07:58PM EDT

Transacciones de accionistas miembros de la empresa

Divisa en USD
Compras de personas con información privilegiada de los 6 últimos mesesAccionesTrans
Compras00
VentasN/A0
Cuotas netas adquiridas (vendidas)00
Acciones de persona con información privilegiada totales2,64MN/A
% de acciones netas adquiridas (vendidas)N/AN/A
Compras institucionales netas del trimestre anterior al último trimestreAcciones
Cuotas netas adquiridas (vendidas)N/A
% de cambio en la posesión de acciones institucionalesN/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiadaTransacciónTipoValorFechaAcciones

ANDERSON GLEN R
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.94 - 2.34 per share.Indirecto216.38814 ago 2023103.352

LITCHEV BOYAN VESSELINOV
Officer

Purchase at price 1.83 - 4.65 per share.Directo2.52001 dic 20221.150

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 1.76 - 1.90 per share.Directo18.94521 nov 202210.000

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 2.80 per share.Directo28.86208 sept 202210.308

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 2.44 - 2.57 per share.Directo24.77107 sept 20229.692

LINSCOTT WALT ADDISON ESQ.
Officer

Purchase at price 2.62 per share.Directo39307 sept 2022150

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 2.63 per share.Directo51.88206 jun 202219.727

NEWMAN MICHAEL JAMES
Officer, Director and Beneficial Owner

Sale at price 5.00 per share.Indirecto100.04301 feb 202220.000

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 5.82 per share.Directo65.10818 nov 202111.187

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 7.00 per share.Directo84.00014 sept 202112.000

DEXCEL PHARMA TECHNOLOGIES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.29 - 0.32 per share.Indirecto281.65904 feb 2020915.951

SILBERMAN ISSAC
Director

Sale at price 0.50 per share.Directo50419 nov 20191.000

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 0.68 per share.Directo13.62028 ago 201920.000

MADDALUNA ANTHONY J
Director

Purchase at price 0.47 per share.Directo11.75027 ago 201925.000

KOZARICH JOHN W.
Director

Purchase at price 0.46 per share.Directo45.90023 ago 2019100.000

MECKLER JEFFREY A
Chief Executive Officer

Purchase at price 0.46 per share.Directo45.70023 ago 2019100.000